Regenxbio Newsroom

Regenxbio Analyst Ratings

BenzingaDec 11 10:54 ET

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsDec 11 07:33 ET

RBC Capital Sticks to Its Buy Rating for RegenXBio (RGNX)

TipRanksDec 11 06:47 ET

REGENXBIO Price Target Cut to $36.00/Share From $40.00 by HC Wainwright & Co.

Dow JonesNov 21 07:01 ET

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $36

Moomoo NewsNov 21 06:31 ET

Buy Rating on RegenXBio Driven by Positive RGX-202 Trial Results and Strong Approval Prospects

TipRanksNov 21 06:19 ET

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsNov 21 05:36 ET

REGENXBIO Price Target Maintained With a $52.00/Share by Chardan Capital

Dow JonesNov 20 06:11 ET

REGENXBIO Is Maintained at Buy by Chardan Capital

Dow JonesNov 20 06:11 ET

Regenxbio Analyst Ratings

BenzingaNov 20 06:01 ET

BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $25

Moomoo NewsNov 19 09:31 ET

Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsNov 19 09:31 ET

Stifel Nicolaus Sticks to Its Buy Rating for RegenXBio (RGNX)

TipRanksNov 19 08:38 ET

A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $18 to $50

Moomoo NewsNov 19 08:01 ET

Promising Developments in RegenXBio's RGX-202 Program Drive Buy Rating

TipRanksNov 18 12:47 ET

Regenxbio Analyst Ratings

BenzingaNov 15 07:05 ET

Morgan Stanley Initiates Regenxbio(RGNX.US) With Buy Rating, Announces Target Price $22

Moomoo NewsNov 15 05:37 ET

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsNov 12 07:36 ET

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsNov 8 05:37 ET

Regenxbio Analyst Ratings

BenzingaNov 7 15:34 ET